p53 plays a major role in the prevention of tumor development. It responds to a range of potentially oncogenic stresses by activating protective mechanisms, most notably cell-cycle arrest and apoptosis. The p53 gene is also induced during normal liver regeneration, and it has been hypothesized that p53 serve as a proliferative 'brake' to control excessive proliferation. However, it has lately been shown that p53 inhibition reduces hepatocyte growth factor-induced DNA synthesis of primary hepatocytes. Here we show that epidermal growth factor (EGF) activated p53 in a phosphatidylinositol-3 kinase-dependent way, and thus induced the cyclin-dependent kinase inhibitor p21
Introduction
The p53 protein is a key tumor-suppressor protein at the crossroads of cellular stress response pathways. Through these pathways, which can lead to cell-cycle arrest, DNA repair, cellular senescence, differentiation or apoptosis, p53 facilitates the repair and survival of damaged cells or the elimination of severely damaged cells from the replicative pool to protect the organism (Hofseth et al., 2004) . In nonstressed cells, p53 levels are typically very low, owing to the rapid degradation of the protein by the ubiquitin/proteasome pathway, a process greatly stimulated by the oncogenic E3 ubiquitin ligase Mdm2 (Vousden and Lu, 2002; Michael and Oren, 2003) . Expression of Mdm2 itself is activated by p53 at the transcriptional level, forming a negative feedback loop (Barak et al., 1993; Wu et al., 2001) .
The native p53 forms tetramers in solution, and functions as a transcription factor that binds to specific DNA sequences. Many p53 mutations, especially those within the DNA-binding domain, show dominance over wild-type protein. Replacement of valine 143 results in a transcriptionally inactive mutant with a transdominantnegative effect on several activities of wild-type p53 (Friedlander et al., 1996; Wong et al., 1999; Monti et al., 2002) . In response to a variety of DNA damaging agents p53 transactivates the expression of various proteins, resulting either in growth arrest or apoptosis.
The p53 transcriptional activity is not restricted to stress responses. Also in normal, proliferating cells p53 is capable of binding DNA and activate transcription (Tang et al., 1998) . Transforming growth factor-a (TGF-a), epidermal growth factor (EGF) receptor and hepatocyte growth factor (HGF) have all been shown to contain p53-responsive elements (Shin et al., 1995; Ludes-Meyers et al., 1996; Metcalfe et al., 1997; Sheikh et al., 1997) . Furthermore, wild-type p53 transcriptionally regulates the EGFR gene via direct DNA binding (Ludes-Meyers et al., 1996) .
The best characterized p53 downstream regulator of growth is the p21
Cip1 gene product (el-Deiry et al., 1993; Harper et al., 1993) . p21 Cip1 protein is usually described as a growth inhibitor in that it selectively inhibits cyclindependent kinase (CDK) holoenzymes, which are required for progression through the cell cycle. However, p21
Cip1 can also play vital pro-proliferative and survival roles. It facilitates the assembly of the D-type cyclins with CDK4 and CDK6 and their subsequent translocation to the nucleus, and prevents their nuclear export (LaBaer et al., 1997; Cheng et al., 1999; Alt et al., 2002) . This results in elevated nuclear levels of active D-type cyclin/CDKs to initiate retinoblastoma protein (pRb) phosphorylation, thereby promoting progression through the G 1 phase of the cell cycle (Sherr and Roberts, 2004) .
Hepatocytes in adult liver are quiescent cells, which efficiently can be made to proliferate given an appropriate stimulus, such as a partial hepatectomy. Similarly, primary hepatocytes isolated from adult liver are recruited from a resting G 0 state into G 1 phase of the cell cycle during cell isolation and plating . Thus, these cells are effectively synchronized before receiving a further proliferative stimulus. The passage from G 0 to G 1 has been defined in hepatocytes by the sequential expression of certain proto-oncogenes, ending with p53 expression in mid-late G 1 . It has been hypothesized that p53 serve as a proliferative 'brake' to control excessive proliferation. Later, it has been shown that p53 inhibition by pifithrina reduces HGF-induced proliferation of hepatocytes (Inoue et al., 2002) .
In the present study, the involvement of p53 in Sphase entry was studied in primary rat hepatocytes, stimulated with EGF. We found a sequential growth factor dependent induction of p53 and p21
Cip1
, and this induction was dependent on an active phosphatidylinositol-3 kinase (PI3 kinase). When p53 was inactivated by transfections with a dominant-negative p53 mutant (p53 V143A ), CDK2-and CDK4 nuclear accumulation and activation was inhibited, as well as hepatocyte DNA synthesis. These effects were neutralized by ectopic expression of p21
. Our results indicated that p53 was involved in the regulation of CDK2-and CDK4 activity through p21
Cip1 expression, and that this effect was initiated by an early EGF-induced PI3 kinase activity.
Results

p53 expression was regulated by EGF through PI3 kinase
We wanted to explore whether p53 induction was EGF regulated in primary rat hepatocytes. As shown in Figure 1a , when the culture medium was supplemented with EGF, cultured cells increased their expression of p53 protein.
p53 levels are closely regulated by the ubiquitin ligase mdm2, which by itself is regulated through PI3 kinase (Latonen et al., 2003; Saito et al., 2005) . Thus, we explored the effects of PI3 kinase inhibition on p53 expression. The induction of p53 was abrogated in EGF stimulated cells when the PI3 kinase was inhibited (Figure 1b) . These results indicated that growth factor regulation of p53 expression was dependent on an active PI3 kinase.
p53 inactivation inhibited EGF-induced S-phase entry and nuclear translocation of CDK4 and CDK2 Pifithrin-a has been described as a p53 inhibitor both in vitro and in vivo. It has been suggested that pifithrin-a inhibits p53 transcriptional activity by obstructing its nuclear translocation (Komarov et al., 1999; Alves da Costa et al., 2002) . Thus, we used pifithrin-a to further explore whether p53 was necessary for EGF-induced S-phase entry. Following thymidine incorporation, we found that pifithrin-a dose dependently inhibited EGFinduced DNA synthesis (Figure 2 ).
Since the specificity of pifithrin-a has not been characterized, and the specific mechanisms of its effects on p53 have not been completely clarified, we wanted to further explore these results with specific inactivation of the p53 protein. A vector containing a dominantnegative p53 mutant (p53 V143A ) was transfected into primary hepatocytes. In this mutant, the DNA-binding domain of p53 is inactivated, preventing p53 transcriptional activity. EGF-stimulated thymidine incorporation of hepatocytes transfected with p53 V143A was compared to cells transfected with a control vector, pEYFP-Mem. DNA synthesis was reduced in a dosedependent way in p53 V143A -transfected cells (Figure 3a ). The amount of thymidine incorporated into DNA was measured in the total pool of hepatocytes, both transfected and untransfected. In average, about 40% of the hepatocytes did express the construct at levels high enough to be detected by immunofluorescence.
Like EGF, TGF-a and HGF are strong hepatocyte mitogens. We next explored the requirement of p53 for DNA synthesis following exposure to these two growth factors. Figure 3b showed that DNA synthesis was reduced also in p53 V143A -transfected cells stimulated with TGF-a or HGF.
To characterize the mechanisms of growth inhibition related to p53 inactivation, we examined whether pRb hyperphosphorylation was affected. The levels of pRb phosphorylation in control-and p53
V143A -transfected cells were compared. As shown in Figure 3c , expression of p53 V143A abolished the pRb phosphorylation induced by EGF. Correspondingly, western immunoblotting confirmed that Thr160 phosphorylation of CDK2, which regulates its kinase activity, was reduced in these cells ( Figure 3c ).
Cyclins D1 and E make complexes with CDK4 and CDK2, respectively, and these complexes promote pRb hyperphosphorylation and proliferation (Weinberg, 1995) . Therefore we explored the expression of cyclins D1 and E following EGF stimulation of transfected cells. The levels of cyclins D1 and E in cells expressing p53
V143A were similar to control-transfected cells during the G 1 phase (Figure 3d ). Thus, p53 effects on DNA synthesis did not appear to be regulated through cyclins. 
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Next, intracellular localization of CDK2 and CDK4 was examined by immunocytochemistry ( Figure 3e ). In control-transfected cells stimulated with EGF, both CDK2 and CDK4 accumulated in the nuclei. However, in cells expressing dominant-negative p53 V143A , CDK2 and CDK4 remained in the cytoplasm after EGF stimulation. This indicated that growth factor induction of p53 regulated hepatocyte S-phase entry through effects on the nuclear import of CDK2 and CDK4.
p53 inactivation inhibited p21
Cip1 induction Because p53 is implicated in regulation of the cyclindependent kinase inhibitor p21 Cip1 in proliferating fibroblasts (Tang et al., 1998) , we wanted to examine if Figure 2 The effect of pifithrin-a on S-phase entry of cultured rat hepatocytes in the presence of epidermal growth factor (EGF). Primary cultures of hepatocytes were exposed to increasing doses of pifithrin-a for 30 min prior to EGF stimulation. The cells were harvested 30 h after EGF stimulation. Thymidine incorporation was measured by scintillation counting. The results represent an average of three separate experiments (s.e.m.; n ¼ 3). 
p53-p21
Cip1 induces S-phase entry L Wierd et al this was also observed in proliferating hepatocytes. Western immunoblotting showed low levels of p21 Cip1 in unstimulated cells. Following EGF stimulation, increasing p21 Cip1 -levels were observed after 24 h (Figure 4a ). p21
Cip1 induction was PI3 kinase dependent, and the protein expression correlated with the pattern of p53 expression (shown earlier in Figure 1a) . Further, western immunoblotting demonstrated that p53 V143A -transfected cells did not express p21
Cip1
, even in the presence of EGF (Figure 4b ). This suggested that p53 regulates the levels of p21
Cip1 following growth stimulation of cultured hepatocytes.
Ectopic p21
Cip1 expression rescued S-phase entry of p53 inhibited hepatocytes As p21
Cip1 is a downstream mediator of p53 in cultured hepatocytes, we next asked whether ectopic expression 
p53-p21
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Cip1 could rescue the growth inhibitory effects of p53 inhibition. We found the negative growth effects of p53 V143A expression to be significantly reduced by coexpression of wild-type p21
Cip1 protein (Figure 5a ). Using immunocytochemistry, we explored the effects on CDK2 and CDK4 nuclear translocation. CDK2 and CDK4 were observed in the cytoplasm of EGFstimulated cells expressing p53 V143A (Figure 5b ). In contrast, EGF-stimulated hepatocytes overexpressing both wild-type p21
Cip1 and p53 V143A showed nuclear accumulation of CDK2 and CDK4.
Immunofluorescence data were confirmed by western immunoblotting analysis of nuclear cell fractions. The nuclear levels of CDK2 and CDK4 were increased in EGF-stimulated cells (Figure 5c ). Expression of p53 V143A reduced this EGF-induced nuclear accumulation, whereas co-expression of p21
Cip1 abrogated the negative effects of p53 V143A on CDK2 and CDK4 nuclear accumulation.
Discussion p53 tumor-suppressor protein regulates many cellular functions. Generally, the major role of p53 is to induce cell-cycle arrest or apoptosis in response to cellular stress, particularly DNA damage (Kastan et al., 1992) . However, new evidences support the concept that p53 might play key roles in extracellular matrix homeostasis and inflammation (Ghosh et al., 2004) . In addition, Inoue and co-workers have suggested that p53 is HGF regulated and indispensable for induction of hepatocyte proliferation (Inoue et al., 2002) . In nonstressed cells, p53 protein levels are typically very low, owing to the rapid degradation of the protein by the ubiquitin/proteasome pathway, a process greatly stimulated by Mdm2 (Vousden and Lu, 2002; Michael and Oren, 2003) . Mdm2 is a phosphoprotein, and it contains several potential PI3 kinase-binding sites of which Ser17 and Ser395 are phosphorylated in vitro and in vivo, respectively (Mayo et al., 1997; Maya et al., 2001) . Akt/PKB has been suggested to regulate the intracellular localization of Mdm2 by phosphorylation on serines 166 and 186 (Zhou et al., 2001) . The PI3 kinase/Akt pathway has been implicated in the regulation of a wide variety of cellular processes, including survival, proliferation, growth, motility and angiogenesis, and is often deregulated in human cancer (Nicholson and Anderson, 2002; Vivanco and Sawyers, 2002) . It has been shown that p53 induction by DNA damage is blocked by inhibition of the PI3 kinase (Bar et al., 2005) . However, inhibition of the PI3 kinase/Akt pathway enhances doxorubicin-induced apoptotic cell death in tumor cells in a p53-dependent manner (Fujiwara et al., 2006) . Since there are conflicting data on the effects of PI3 kinase inhibition on p53 expression in different cell types, we explored this in cultured hepatocytes. We found that EGF-induced p53 induction was dependent upon an active PI3 kinase.
The involvement of p53 in proliferation is not well understood. However, some studies point to a role of p53 as an enhancer of transcriptional activity of growth regulatory genes. It has been shown that endogenous p53 in serum-stimulated cell lines is capable of DNA binding and transcriptional activation (Tang et al., 1998) . In particular, p53 can act as a transcription factor and activate both the HGF and TGF-a promoters (Shin et al., 1995; Metcalfe et al., 1997) as well as the human EGF receptor promoter (Ludes-Meyers et al., 1996; Sheikh et al., 1997) . In human diploid fibroblast cell lines, it has been reported that a reduced production of p53, by a p53 antisense oligonucleotide, resulted in inhibition of DNA synthesis and cell-cycle arrest in the G 0 /G 1 phase (Hirota et al., 1996) . Furthermore, it has been shown that p53 inhibition by pifithrin-a reduces HGF-induced proliferation of hepatocytes (Inoue et al., 2002) . In contrast, during in vivo liver regeneration, antisense suppression of p53 induction resulted in lack of the G 1 /S cell-cycle checkpoint activity and enhanced proliferation (Arora and Iversen, 2000) . This discrepancy might reflect differences in our cell culture model and liver regeneration in an intact organ.
To approach these seemingly contrasting effects of p53 on S-phase entry, we studied growth factor induction of p53 and its regulation of DNA synthesis in primary cultures of hepatocytes. We found reduced DNA synthesis in hepatocytes when wild-type p53 was over expressed (data not shown). This is in line with V143A , 15 h prior to EGF stimulation. Hepatocytes were harvested 24 h after EGF stimulation. Western immunoblot analysis was carried out on lysates with antisera to p21
Cip1 and p53. In both panels a and b, the protein expression of b-tubulin was used as a loading control. Representative examples of at least three experiments are shown.
Cip1 induces S-phase entry L Wierd et al other studies reporting that p53 can induce cell-cycle arrest in G 1 phase (Diller et al., 1990; Kastan et al., 1992; Lin et al., 1992) . However, downregulation of p53 by pifithrin-a or a p53 dominant-negative mutant resulted in reduced proliferation, which strongly suggested that p53 may have a dual role.
In culture, hepatocytes progress through G 1 regardless of growth factor stimulation until the restriction point (R point) in mid-late G 1 , beyond which they cannot progress without mitogenic stimulation (Loyer et al., 1996) . At this point, addition of EGF leads to cyclin D1 induction and complex formation between cyclin D1 and CDK4. The other CDK important for mitogen-induced G 1 progression is CDK2, which complexes with cyclin E. In late G 1 phase, both holoenzymes translocate to the nucleus and sequentially phosphorylates the pRb protein, which results in G 1 /S transition (Lundberg and Weinberg, 1998) . In hepatocytes, PI3 kinase activity is important for both cyclin D1 mRNA and protein expression (Coutant et al., 2002) . Since p53 is downstream of PI3 kinase, we explored if induction of cyclin D1 was affected by p53 inactivation. Our results demonstrated that the induction of cyclin D1 was unchanged whether p53 was inactivated or not. Thus, induction of cyclin D1 and p53 protein represents two separate pathways downstream of PI3 kinase.
Since neither the level of cyclins D1 nor E was regulated by p53, their catalytic partners CDK4 and CDK2 were studied. To become active, cyclin-CDK complexes have to accumulate in the nucleus (Matsuoka et al., 1994; Tassan et al., 1994) . Our results implied that nuclear accumulation occurs through a PI3 kinase p53-dependent pathway. This suggested a novel mechanism for PI3 kinase in the regulation of cell-cycle progression.
Nuclear translocation of cyclin D-CDK4 complexes may rely on piggybacking on p21
Cip1
, which contains separate N-terminal cyclin and CDK-binding sites and a C-terminal nuclear localization signal (NLS) (Gallant et al., 1995; Diehl and Sherr, 1997; LaBaer et al., 1997) . Cyclin E also contains NLS, thus cyclin E-CDK2 complexes may translocate to the nucleus independently of p21
Cip1 piggybacking. However, it has recently been suggested that the NLS of cyclin E is not functional (Kelly et al., 1998; Geisen and Moroy, 2002) . In cultured hepatocytes, it has been demonstrated that p21 Cip1 protein levels increased in a mitogen-dependent manner and its expression pattern correlated with that of cyclin D1 (Ilyin et al., 2003) . We confirmed that the induction of p21
Cip1 was EGF dependent in rat hepatocytes and that protein expression relied on an active PI3 kinase. Furthermore, we found that p53 regulated p21
, not only in DNA-damaged cells, but also in normal proliferating hepatocytes. Inactivation of p53 led to reduced DNA synthesis, but this effect was almost recovered by co-expression of p21 Cip1 protein. These findings supported the hypothesis that p21 Cip1 stimulated nuclear translocation of CDKs and that p21
, like p53 has a dual role in the regulation of cell-cycle progression.
Taken together, these observations argue strongly that EGF-induced p53 and p21
Cip1 expression, via an active PI3 kinase, is important for CDK2 and CDK4 nuclear translocation and S-phase entry. We suggest that p53 and p21
Cip1 have dual roles in the regulation of growth arrest and DNA synthesis in primary rat hepatocytes.
Materials and methods
Materials
Williams' medium E, Dulbecco's modified Eagle's medium, penicillin and streptomycin were from Gibco (Grand Island, NY, USA). Collagenase (C-0130), collagen (C-7661), dexamethasone (D-4902), EGF (E-1257), HGF (H-1404) and insulin (I-6634) were obtained from Sigma-Aldrich (St Louis, MO, USA). LY294002 and pifithrin-a were from Calbiochem (La Jolla, CA, USA). TGF-a was obtained from Bachem (Weil am Rhein, Germany). Thymidine was obtained from GE Healthcare (London, UK). Rabbit anti-phosphorylated Rb and rabbit anti-phosphorylated CDK2 from Cell Signaling Technology (Beverly, MA, USA), rabbit anti-cyclin D1 and mouse anti-p21 from Upstate Biotechnology (Lake Placid, NY, USA), mouse anti-b-tubulin from Sigma-Aldrich, mouse anti-HA from Covance (Berleley, CA, USA), mouse anti-LAP2 from Transduction Laboratories (Lexington, KY, USA), rabbit anti-CDK2 and rabbit anti-CDK4 from Santa Cruz Biotechnology (Santa Cruz, CA, USA) and rabbit anticyclin E and rabbit anti-p53 from Abcam (Cambridge, UK). Horseradish peroxidase-conjugated goat anti-rabbit immunoglobulin G (IgG) and donkey anti-mouse IgG were obtained from Sigma-Aldrich. Cy3-conjugated donkey anti-rabbit IgG antibody was purchased from Jackson Immunoresearch (West Grove, PA, USA).
Cell isolation and culture
Young adult male Wistar rats (Mllerga˚rd and Bomhoff, Odense, Denmark) weighing 200-220 g were kept on a 12 h light/dark cycle and fed ad libitum. Hepatocytes were isolated and seeded as previously described (Skarpen et al., 2000; Rosseland et al., 2005) . The cultures were kept in 5% CO 2 at 37 1C. Hepatocytes were exposed to 10 nM EGF. For inhibition assays, the cells were preincubated with inhibitor 1 h before addition of EGF.
Western immunoblot analysis and nuclear fractionation Western blot analysis was performed as previously described (Skarpen et al., 2000; Rosseland et al., 2005) . Equal protein V143A , p21 Cip1 wild type or from cells co-transfected with p53 V143A and p21 Cip1 wild type. Western immunoblot analysis was carried out on the nuclear fractions with antisera recognizing CDK4, CDK2 and LAP2, which are enriched in nuclear membranes.
p53-p21
Cip1 induces S-phase entry L Wierd et al loading was controlled with an antibody to b-tubulin. For nuclear fractionation, hepatocytes were lysed for 10 min on ice in 10 mM sodium phosphate buffer (pH 7,4) containing 10 mM NaCl, 5 mM MgCl 2 , 0.1% NP40, 0.2 mM 4-(2-aminoethyl) benzenesulfonyl fluoride hydrochloride, 20 mM leupeptin, 200 units per ml aprotinin, 65 mM sodium orthovanadate and 10 mM b-glycerophosphate. The cells were homogenized by 20 strokes with a tight-fitting homogenizer. Nuclei were collected via centrifugation at 900 g for 10 min at 4 1C and prepared for western blot analysis.
Measurement of DNA synthesis
For thymidine incorporation cells were cultured in six-wells plates and grown as described above. [ 3 H]-thymidine (1 mCi ml À1 ) was added to the cultures 48 h after plating. DNA synthesis was assessed by determining the amount of radioactivity incorporated into DNA. The cellular material was precipitated with 2 ml 5% trichloroacetic acid for 2 Â 10 min. The acid-precipitated material was dissolved in 0.6 ml 1 M KOH, followed by liquid scintillation counting. Protein was measured as earlier described.
Rat hepatocyte transfection
Transfection was carried out with DOTAP reagent (Biontex Laboratories, Martinsried, Germany) according to the manufacturer's instructions. The pMEV-p53-DN (V143A) vector was obtained from Biomyx Technology (San Diego, CA, USA) and the wild-type p21
Cip1 plasmid was kindly provided by Heidi K Blomhoff (Naderi et al., 2005) . The pEYFP-Mem vector (Clontech, Mountain View, CA, USA) encodes a fusion protein consisting of the N-terminal 20 amino acids of neuromodulin and a yellow-green fluorescent variant of the enhanced green fluorescent protein. EGF was added 15 h after transfection and cells were harvested at different time points following growth factor addition. Fluorescence microscopy counting of hepatocyte cultures transfected with pEYFP-Mem indicated a transfection efficiency of about 40%.
Immunocytochemistry and confocal immunofluorescence microscopy Immunofluorescence staining was performed as previously described (Skarpen et al., 2000; Rosseland et al., 2005) . The immunostained cells were examined with a Leica TCS SP confocal microscope (Leica, Heidelberg, Germany) equipped with Ar (488 nm) and two He/Ne (543 and 633 nm) lasers and LCS software. A Â 40 oil objective was used.
